Medicare Enrolled

Dr. Jashvant Patel, M.D.

Optician · San Luis Obispo, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10 SANTA ROSA ST, San Luis Obispo, CA 93405
8055447246
In practice since 2006 (20 years)
NPI: 1619955994 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Jashvant Patel is an optician specialist in San Luis Obispo, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 6,231 Medicare services across 1,871 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $6,033 from 29 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 14% volume in CA $6,033 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,231
Medicare services
Top 14% in CA for optician
1,871
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~312 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
3,118 $100 $450
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
1,192 $61 $550
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
581 $67 $195
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
209 $269 $20,809
Spinal drug pump reprogramming and refill
A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir.
188 $79 $415
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
188 $50 $600
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
147 $97 $2,161
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
115 $79 $800
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
114 $80 $1,442
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $130 $375
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
57 $217 $2,526
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
54 $85 $1,612
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
41 $90 $1,936
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
40 $35 $525
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
37 $99 $1,395
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
26 $42 $1,200
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $27 $195
Minimally invasive spine decompression, lower spine
A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin.
12 $472 $7,700
Spinal neurostimulator generator insertion
Surgical placement of a spinal neurostimulator generator or receiver device.
11 $201 $7,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,033
Total received (2018-2024)
Avg $862/year across 7 years
Top 20% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,868 (80.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$743 (12.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$421 (7.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,604
2023
$831
2022
$363
2021
$693
2020
$131
2019
$314
2018
$1,096

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,143
Boston Scientific Corporation
$880
TerSera Therapeutics LLC
$421
BIOTRONIK NRO, Inc.
$96
Avanos Medical
$24
Bioventus LLC
$20
ABBVIE INC.
$20
Top 3 companies account for 93.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,023
Medtronic USA, Inc.
$976
Boston Scientific Corporation
$937
TerSera Therapeutics LLC
$484
BOSTON SCIENTIFIC CORPORATION
$368
Vertiflex, Inc.
$171
ABBVIE INC.
$154
Vertos Medical, Inc.
$138
PFIZER INC.
$106
BIOTRONIK NRO, Inc.
$96
PAINTEQ LLC
$67
SI-BONE, Inc.
$65
Electronic Waveform Lab, Inc.
$58
AbbVie Inc.
$54
Abbott Laboratories
$47
DePuy Synthes Sales Inc.
$47
Stryker Corporation
$29
Daiichi Sankyo Inc.
$25
Avanos Medical
$24
Assertio Therapeutics, Inc.
$24
Bioventus LLC
$20
Supernus Pharmaceuticals, Inc.
$20
Almatica Pharma LLC
$19
Collegium Pharmaceutical, Inc.
$16
Horizon Therapeutics plc
$14
Purdue Pharma L.P.
$14
IBSA Pharma Inc.
$12
AstraZeneca Pharmaceuticals LP
$12
Shionogi Inc
$11
Top 3 companies account for 65.2% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · ASCENDA · Cambia · DUEXIS · DUROLANE · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENVISC 850 SODIUM HYALURONATE · GRALISE · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · LYRICA · Licart · MONOVISC · MOVANTIK · Morphabond ER · ORTHOVISC · PAINTEQ · PROCLAIM · Prialt · Proclaim IPG · Prospera · QULIPTA · RESTORE · REYVOW · SPINEJACK · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Superion · Superion ISS · Symproic · TROKENDI XR · UBRELVY · VANTA ADAPTIVESTIM · WAVEWRITER ALPHA · XTAMPZAER · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in San Luis Obispo?
Compare opticians in the San Luis Obispo area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
41
Per 100K population
14.6
County median income
$93,398
Nearest hospital
ADVENTIST HEALTH SIERRA VISTA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Patel performed 3,118 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $6,033 from 29 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other opticians in San Luis Obispo?
Dr. Patel's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →